Cargando…
Recent Advances in Molecular Diagnostics and Targeted Therapy of Myeloproliferative Neoplasms
SIMPLE SUMMARY: Myeloproliferative neoplasms (MPN) are clonal hematologic malignancies with dysregulated myeloid blood cell production driven by JAK2, calreticulin, and MPL gene mutations. Technological advances have revealed a heterogeneous genomic landscape with additional mutations mainly in epig...
Autores principales: | Stivala, Simona, Meyer, Sara C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534234/ https://www.ncbi.nlm.nih.gov/pubmed/34680185 http://dx.doi.org/10.3390/cancers13205035 |
Ejemplares similares
-
Targeted therapies for myeloproliferative neoplasms
por: Li, Bing, et al.
Publicado: (2019) -
Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms
por: Brkic, Sime, et al.
Publicado: (2020) -
Recent insights regarding the molecular basis of myeloproliferative neoplasms
por: Jang, Mi-Ae, et al.
Publicado: (2020) -
Recent advances in diagnosis and treatment of chronic myeloproliferative neoplasms
por: Guglielmelli, Paola, et al.
Publicado: (2010) -
Synoptic Diagnostics of Myeloproliferative Neoplasms: Morphology and Molecular Genetics
por: Nann, Dominik, et al.
Publicado: (2021)